DEBIO1347, AN ORAL FGFR INHIBITOR: RESULTS FROM A SINGLE CENTER STUDY IN PEDIATRIC PATIENTS WITH RECURRENT/REFRACTORY FGFR ALTERED GLIOMAS

Sait, SF; Rosenblum, M; Bale, T; Haque, S; Gilheeney, S; Spatz, K; Prince, D; Ibanez, K; Dunkel, I; Karajannis, M

NEURO-ONCOLOGY, 2020; 22 (): 50